Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iChip01:24

iChip

107
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
107

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infection.

Nature medicine·2026
Same authorSame journal

Refining the regulatory and ethics context of controlled human infection models - a stakeholder meeting report.

Biologicals : journal of the International Association of Biological Standardization·2026
Same author

Influenza coinfection inhibits control of mycobacterial infection in a human challenge model.

Nature communications·2026
Same author

Public Knowledge and Attitudes Towards Clinical Trial Participation: A Mixed-Method Study in Bagamoyo District, Tanzania.

International journal of environmental research and public health·2026
Same author

Modelling the Cost-Effectiveness of a Placental Malaria Vaccine in Sub-Saharan Africa.

Vaccines·2026
Same author

Second regulatory workshop on utilising in silico models to expedite vaccine development, testing, and lifecycle management - an expert meeting report.

Vaccine·2026

Related Experiment Video

Updated: May 5, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.6K

Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023.

Melissa Kapulu1, Lucinda Manda-Taylor2, Shobana Balasingam3

  • 1KEMRI-Wellcome Trust Research Programme, Kenya.

Biologicals : Journal of the International Association of Biological Standardization
|February 13, 2024
PubMed
Summary

Controlled Human Infection Models (CHIMs) are expanding globally, especially in Africa, using diverse challenge organisms. Continued community engagement and ethical oversight are crucial for successful implementation and capacity building.

Keywords:
Deliberate infectionEndemic diseasesHuman challengeHuman infection studiesInfectious diseasesLow- and middle-income countriesVaccine

More Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.6K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

9.0K

Related Experiment Videos

Last Updated: May 5, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.6K
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.6K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

9.0K

Area of Science:

  • Infectious Diseases
  • Clinical Trials
  • Public Health

Background:

  • Controlled Human Infection Models (CHIMs), also known as human challenge studies, have established foundational elements including GMP production, ethical considerations, safety, recruitment strategies, and endpoint definitions.
  • Recent advancements have focused on expanding CHIMs into endemic countries, particularly in Africa.

Purpose of the Study:

  • To review the progress and challenges of Controlled Human Infection Models (CHIMs) conducted in endemic countries.
  • To highlight the expansion of CHIM studies in Africa and the increasing diversity of challenge organisms used.

Main Methods:

  • The study is based on discussions and outcomes from the fourth CHIM meeting, focusing on practical aspects of conducting these studies in diverse settings.
  • Review of existing initiatives in regulation and capacity building for CHIMs.

Main Results:

  • A significant increase in the number of African countries conducting CHIM studies over the past decade.
  • Growing diversity in the types of challenge organisms employed in CHIMs.
  • Emphasis on the critical role of community and public engagement, alongside robust ethical and regulatory oversight.

Conclusions:

  • Community-led or community-driven engagement models are recommended for future CHIM studies.
  • While regulatory initiatives are valuable, further capacity building is essential for the sustainable growth of CHIMs globally.
  • Continued focus on ethical considerations and community involvement is paramount for the successful and responsible implementation of CHIMs.